Cadence Capital Management’s Amgen AMGN Stock Holding History

Cadence Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$3.15M	Sell	12,403 -3,155	-20%	-$782K	0.76%	18
2020 Q2	$3.67M	Sell	15,558 -244	-2%	-$55.7K	0.53%	16
2020 Q1	$3.2M	Sell	15,802 -5,568	-26%	-$1.22M	0.54%	30
2019 Q4	$5.15M	Sell	21,370 -1,487	-7%	-$328K	0.56%	25
2019 Q3	$4.42M	Sell	22,857 -286	-1%	-$54.9K	0.63%	25
2019 Q2	$4.26M	Sell	23,143 -5,730	-20%	-$1.03M	0.43%	37
2019 Q1	$5.49M	Sell	28,873 -589	-2%	-$112K	0.49%	41
2018 Q4	$5.74M	Sell	29,462 -32,394	-52%	-$6.32M	0.58%	33
2018 Q3	$12.8M	Sell	61,856 -12,342	-17%	-$2.43M	0.69%	31
2018 Q2	$13.7M	Sell	74,198 -1,716	-2%	-$304K	0.81%	16
2018 Q1	$12.9M	Buy	75,914 +5,919	+8%	+$1.09M	0.84%	15
2017 Q4	$12.2M	Sell	69,995 -1,736	-2%	-$307K	0.77%	29
2017 Q3	$13.4M	Sell	71,731 -3,186	-4%	-$565K	0.84%	19
2017 Q2	$12.9M	Sell	74,917 -2,092	-3%	-$340K	0.89%	13
2017 Q1	$12.6M	Sell	77,009 -6,370	-8%	-$1.06M	0.87%	21
2016 Q4	$12.2M	Buy	83,379 +12,581	+18%	+$1.89M	0.85%	20
2016 Q3	$11.8M	Sell	70,798 -10,080	-12%	-$1.7M	0.86%	23
2016 Q2	$12.3M	Sell	80,878 -3,433	-4%	-$534K	0.93%	19
2016 Q1	$12.6M	Sell	84,311 -1,915	-2%	-$285K	0.89%	23
2015 Q4	$14M	Buy	86,226 +80,204	+1,332%	+$12.6M	0.94%	12
2015 Q3	$833K	Buy	+6,022	New	+$949K	0.06%	343
2014 Q1	–	Sell	-53,515	Closed	-$6.11M	–	588
2013 Q4	$6.11M	Buy	53,515 +11,435	+27%	+$1.3M	0.23%	153
2013 Q3	$4.71M	Sell	42,080 -32,190	-43%	-$3.49M	0.16%	260
2013 Q2	$7.33M	Buy	+74,270	New	+$7.71M	0.34%	144

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cadence Capital Management's AMGN Position: Q3 2020 in Review

Cadence Capital Management reduced its Amgen (AMGN) stake by 20% in Q3 2020, selling an estimated $782K and leaving 12,403 shares worth $3.15M. The position accounts for 0.76% of the portfolio, ranked #18.

Cadence Capital Management first reported a position in AMGN in Q2 2013 and has held it in 24 quarters since. The position peaked at $14M in Q4 2015. 2,127 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

Cadence Capital Management held 12,403 shares of Amgen worth $3.15M as of Q3 2020.
Cadence Capital Management sold 3,155 Amgen shares in Q3 2020, an estimated $782K.
Amgen made up 0.76% of Cadence Capital Management's portfolio in Q3 2020, its #18 holding.
Cadence Capital Management first reported a position in Amgen in Q2 2013 and has held it in 24 quarters since.
Cadence Capital Management's Amgen position peaked at $14M in Q4 2015.
2,127 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.